Published on 01/12/2025

IQ/OQ/PQ for Lines: Printers, Cameras, Re-Work Tables

Understanding Qualification: IQ, OQ, and PQ for Serialization Lines

The qualification process for pharmaceutical manufacturing equipment is essential to ensuring compliance with regulatory standards such as current Good Manufacturing Practices (cGMP). This process is encapsulated in the Installation Qualification (IQ), Operational Qualification (OQ), and Performance Qualification (PQ) stages. Serialization lines, including printers and cameras, require thorough qualification due to their role in ensuring data integrity and compliance with regulations like the Drug Supply Chain Security Act (DSCSA) and the European Falsified Medicines Directive (EU FMD).

By defining the purpose and scope of the qualification process, stakeholders can ensure that all critical parameters of equipment functionality and data tracing capabilities are evaluated accurately. The following guide outlines the sequential steps required to effectively implement IQ, OQ, and PQ for serialization lines.

Step 1: Define User Requirements Specifications (URS)

Developing User Requirements Specifications (URS) is the foundational step in the qualification process. URS defines the specific needs and expectations of the stakeholders concerning the equipment’s performance. For printers, cameras, and re-work tables, the URS should address the following:

• Performance Criteria: Outline the expected output and functionality, such as print quality, speed, and scanning capability.
• Compliance Needs: Detail how the equipment will help meet DSCSA compliance requirements and aggregate hierarchy.
• Data Integrity Guidelines: Highlight requirements aligned with ALCOA+ principles to ensure the authenticity and complete traceability of the serialization process.

Once the URS is established, it should be reviewed and approved by all relevant stakeholders. This document will serve as a guide throughout the qualification stages and will ensure adherence to regulations and internal quality management processes.

Step 2: Installation Qualification (IQ)

The Installation Qualification (IQ) phase verifies that the equipment is installed correctly according to its specifications and the requirements outlined in the URS. The following activities are critical in this phase:

• Verification of Installation: Ensure that all hardware components and software applications are installed and operating according to manufacturer specifications.
• Documentation Review: Collect and organize all relevant documentation such as installation manuals, certificates, and specification sheets.
• Environmental Checks: Confirm that the installation environment meets compatibility needs regarding temperature, humidity, and power requirements.

Upon completion of the IQ, a report should be executed that documents all activities, findings, and any deviations encountered during the process. This document serves to provide evidence of compliance and readiness for the next phase, OQ.

Step 3: Operational Qualification (OQ)

The Operational Qualification (OQ) assesses whether the equipment functions according to its intended operational characteristics under predefined operating conditions. This phase will involve the following key activities:

• Testing of Key Functionalities: Each functionality defined in the URS must be systematically tested. For instance, the printer’s various print modes, camera scanning efficiency, and the re-work table’s processing capabilities should be evaluated.
• Establishing Limits and Ranges: Testing should be conducted within defined limits. For example, print quality should be assessed based on the acceptable range of resolution, while camera scans should be benchmarked based on accuracy rates.
• Exception Handling Protocols: Establish and validate protocols for handling exceptions such as communication errors between hardware and software systems. This includes documenting corrective actions and adjustments.

The results of the OQ phase must be documented in a comprehensive report that reflects testing outcomes, any discrepancies noted, and recommendations for corrective measures. This report is essential for demonstrating compliance with regulations and managing data integrity risks effectively.

Step 4: Performance Qualification (PQ)

The Performance Qualification (PQ) ensures that the equipment performs effectively in a real-world scenario, simulating actual operating conditions over a defined period. This part of the qualification process includes:

• Validation of Process Performance: Evaluate the equipment’s performance using actual product runs to simulate the conditions under which it will operate. Gather data on serialization success rates and operational efficiency.
• Monitoring and Data Logging: Employ monitoring systems to log performance data during the PQ test runs. Ensure that data is continuously tracked and stored according to ALCOA+ principles for audit trail review.
• Documentation Review: Document the performance metrics achieved during testing. This should include any deviations from expected performance benchmarks and the resultant action plans.

The PQ report should finalize the qualification process by consolidating all findings from IQ and OQ stages while linking back to compliance with regulatory frameworks such as those established by the FDA and EMA. Upon approval, the serialization equipment can enter routine operation with ongoing verification measures in place.

Step 5: Change Control and Continuous Monitoring

After the completion of the IQ, OQ, and PQ phases, maintaining compliance requires an active change control system. This process ensures that any modifications to the serialization line, be it equipment updates, software changes, or process alterations, are documented and assessed for impact on the qualification status. Steps involved include:

• Assessing Impact: Evaluate how changes will affect existing functionalities and compliance with serialization guidelines such as DSCSA.
• Requalification Needs: Determine if the change necessitates re-qualification and adjust plans accordingly.
• Regular Audits: Conduct periodic audits of serialization processes, focusing on data flows and adherence to reconciliation rules.

Engaging in continuous monitoring plays a crucial role in ensuring the long-term effectiveness of serialization processes and upholding data integrity. Regularly reviewing master data governance will further enhance the solid framework necessary for compliance.

Conclusion: Ensuring Compliance through Effective Qualification Practices

The process of qualification in pharmaceutical serialization is pivotal in ensuring that equipment such as printers, cameras, and re-work tables operate optimally for regulatory compliance. By following the structured steps of developing a comprehensive URS, conducting IQ, OQ, and PQ, and maintaining an effective change control system, organizations can mitigate risks and ensure data integrity throughout their processes. This adherence not only meets the expectations of authorities such as the FDA, EMA, and MHRA but also solidifies a culture of quality and regulatory compliance that is essential in today’s pharmaceutical landscape.

For more details, refer to the FDA’s guidance documents and additional resources from EMA and WHO to align organizational practices with established compliance measures across jurisdictions.